89600 Investors following Bharti Airtel. Share this News with them.
0
Like this story, share it with millions of investors on M3
Houseviews: Get brokerage advice on 4 stocks here!
CLSA has an underperform rating on Bharti Airtel with a target of Rs 355. A mere 1% sequential growth in India-mobile traffic and a 150 bps drop in EBITDA margin coupled with a jump in depreciation and taxation led to profits being 30% below estimates.
CLSA has an underperform rating on Bharti Airtel with a target of Rs 355. A mere 1% sequential growth in India-mobile traffic and a 150 bps drop in EBITDA margin coupled with a jump in depreciation and taxation led to profits being 30% below estimates. Upcoming spectrum payments will hit Bharti's deleveraging efforts.
JPMorgan maintains overweight on ONGC with a target of Rs 335. Retrospective royalty recovery from cairn helped offset a sharply higher subsidy payout in the third quarter. While the increase in subsidy share for the upstream is sentiment-negative, ONGC remains comparatively resilient to adverse policy.
Nomura maintains its reduce stance on Tech Mahindra with a target of Rs 580. The stock has run up by 8% over the last month, outperforming the CNX IT index by 6%. Nomura expects significant downside to the stock at current levels.
Macquarie has downgraded Orchid Chemicals to a neutral from outperform and cut its target to Rs 170 from Rs 260. Orchid has revised down its FY12 sales guidance by 11% and profit by over 7%. While the valuation is attractive, the stock is likely to come under pressure in the near-term given the earnings miss.
